Alvogen Announces Expansion in Romania
First products scheduled for market introduction early in 2010
January 14, 2010 06:03 AM Eastern Time
PARSIPPANY, N.J.--(EON: Enhanced Online News)--Alvogen, Inc. (Alvogen), the U.S.-based pharmaceutical company, toda
has expanded operations in Eastern Europe and has opened an office in Bucharest, Romania. Alvogen Romania primarily will foc
marketing to support several new products scheduled for introduction during 2010. The company also will employ regulatory and p
expertise within the newly formed business.
“We see great opportunities for our business in Eastern Europe, and the creation of Alvogen Romania is integral to our development
registration of our own products, portfolio acquisitions and strategic partnerships, we aim to build a strong presence in the market w
product offering,” said Robert Wessman, Executive Chairman of Alvogen. Wessman is the former chief executive of Actavis,
generic pharmaceutical companies in the world.
Alvogen Romania will be led by Laurentiu Scheusan, a recognized expert in the Romanian pharmaceutical market who formerly
operations for generic pharmaceuticals company Actavis. In his role as Managing Director of Alvogen Romania, Scheusan will
new employees who have measurable experience within the local pharmaceutical industry.
The well-established, Romanian pharmaceutical market generates annual sales totaling $3 billion (USD), and Alvogen believes the
experience strong growth as the Romanian healthcare infrastructure improves.
“Within the next five years we aim to be one of the leading pharmaceutical companies in Romania, based upon our reputation of hig
and services,” said Doug Drysdale, Chief Executive Officer of Alvogen. “It is our vision to set a new standard for the generic
business, enhance the quality of life for patients and deliver exceptional value to our customers,” said Drysdale.
Alvogen is a multinational pharmaceuticals company focused on complex generic products. Alvogen is committed